Aetna targets LGBT community as insurers seek ways to market more to individual customers
Aetna is urging gay customers to "be proud" — and consider buying its coverage — as part of a new, narrow focus to selling health insurance in a business where the individual's buying decision matters more than it used to.
A glance at some of the insurers wrestling with nursing-home bills
Life insurance firms used to pitch long-term care policies as the prudent way for Americans to shoulder the cost of staying in nursing homes.
FDA approval of Novartis drug opens door to lower-cost biotech medicines in US
Federal health officials say they approved the first lower-cost copy of a biotech drug, a long-awaited milestone that could generate billions in savings for insurers, doctors and patients.
Obama administration unveils plan to shift Medicare payments, rewarding quality vs. quantity
The Obama administration is unveiling what it calls a historic shift in the way Medicare pays hospitals and doctors.
Consumer group sues Aetna, says mail-order drug policy discriminates against people with HIV
A consumer advocacy group has filed a class-action lawsuit against Aetna Inc. saying a new policy violates the privacy of people with HIV and AIDS by requiring them to get their medications from its mail-order pharmacy.
Medicare Advantage Enrollment Deadline Looms
Millions of Medicare Advantage customers are fast approaching a deadline for a task they'd rather avoid: Researching and then settling on coverage plans for 2015.
As drugmakers and hospitals cut costs and sharpen focus, health care deals lead global surge
In a big year for deal making, the health care industry is a standout.
Genworth, Whole Foods, Kate Spade, Qualcomm and Tesla Motors are big market movers
Stocks that moved substantially or traded heavily Thursday on the New York Stock Exchange and the Nasdaq Stock Market: NYSE Genworth Financial Inc., down $5.41 to $8.66 The financial services company reported a quarterly loss on higher costs, and the results fell short of Wall Street expectations.
Drugmaker wins approval for breakthrough hepatitis C drug, but price remains an issue
Federal health officials have approved a daily pill that can cure the most common form of hepatitis C without the grueling pill-and-injection cocktail long used to treat the virus.
Wal-Mart Eliminates Health Care Insurance Coverage for Most Part-Time Workers
Wal-Mart will eliminate health insurance coverage for most part-time employees in a move aimed at controlling rising health care costs for the retailer.
South Dakota proposal that could increase doctor choice for patients splits medical community
South Dakota medical patients could have more choice of doctors within their health insurance networks if voters approve a ballot measure that is drawing strong opposition from the health insurance industry.
Highmark sues University of Pittsburgh Medical Center, claims $300M cancer drug overbilling
Health insurer Highmark Inc. has sued the University of Pittsburgh Medical Center claiming the hospital network has overbilled it by $300 million for cancer drugs.
Highmark sues University of Pittsburgh Medical Center, claims $300M cancer drug overbilling
Health insurer Highmark Inc. has sued the University of Pittsburgh Medical Center claiming the hospital network has overbilled it by $300 million for cancer drugs.
Pennsylvania Insurance Department, Highmark spell out coverage plan after UPMC split
Health insurer Highmark Inc. and the Pennsylvania Insurance Department have spelled out a plan for Highmark customers to continue using doctors and some hospitals from the rival University of Pittsburgh Medical Center once Highmark's provider agreement with UPMC ends Jan. 1.
Louisiana attorney general sues State Farm, accusing insurer of unsafe auto repair practices
Attorney General Buddy Caldwell filed a lawsuit Tuesday against State Farm, alleging Louisiana's largest auto insurer is illegally steering customers involved in car accidents to repair shops that use junkyard parts and choose cheap fixes over safety.
Allergan sues rival drugmaker Valeant and partner, alleging fraud in hostile takeover attempt
Botox maker Allergan is suing a Canadian drugmaker and a hedge fund over their hostile takeover attempt, alleging insider trading and other fraud before their plan became public.
Despite outcry over cost, breakthrough drug becomes treatment of choice for hepatitis C
A $1,000-per-pill drug that insurers are reluctant to pay for has quickly become the treatment of choice for a liver-wasting viral disease that affects more than 3 million Americans.
Aetna 2Q profit increases 2.4 percent, tops forecast
Aetna Inc. (AET) on Tuesday reported profit that climbed by 2.4 percent in its second quarter, and topped analysts' expectations.
Virus drugmaker fights back against pediatricians group's limits on medicine use for preemies
A costly drug given mostly to premature babies is at the center of a clash between the manufacturer and the nation's leading pediatrician's group, which recommends scaling back use of the medicine.
Faith-affiliated nonprofits' contraceptive challenge is next health law case for Supreme Court
How much distance from an immoral act is enough?

